Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Gold & silver

Small Cap Watch: Small Ordinaries firmer as gold, rare earths and biotech updates drive the morning news

The S&P/ASX Small Ordinaries (XSO) closed at 3,964.40, up 24.30 (0.62%) yesterday and is up 20.80 (0.53%) over the past five days.

Against that firmer small-caps backdrop, we have several companies with news this morning. You can read about the following and more throughout the day.

Pantoro Gold

Pantoro Gold Ltd (ASX:PNR, OTC:PNTOF, FRA:RKN) reported December 2025 quarter production of 22,071 oz and sales of 22,473 oz at an average realised price of $6,077/oz. All-in sustaining costs were $2,571/oz, supporting EBITDA of $83.6 million. Cash and gold increased $35.0 million to $216.5 million, despite $32.1 million of investment across exploration ($14.5 million) and major project capital ($17.7 million).

Operationally, Scotia Underground completed 2,018 m of development and produced 102,291 t at 3.00 g/t Au, with extensional drilling supporting high-grade mineralisation in southern and central areas. OK Underground delivered 7,081 oz from 51,103 t at 4.31 g/t Au, while transition works at O2 Lode continued. Open pit mining advanced at Princess Royal, with Desirables completed and Slippers expected to finish in January 2026. Early stripping started at Gladstone, with first ore targeted for the March 2026 quarter.

Ionic Rare Earths

Ionic Rare Earths Ltd (ASX:IXR, OTC:IXRRF) said its ordinary shares had been approved for trading on the OTCQB Venture Market in the US under ticker IXRRF. The company linked the move to efforts to broaden its international investor base and referenced a prior MoU with Missouri-based US Strategic Metals (USSM) and its stated focus on developing supply chains outside China.

Entropy Neurodynamics

Entropy Neurodynamics Ltd (ASX:ENP, OTC:TYPTF) reported the first Binge Eating Disorder (BED) patient treated with TRP-8803 (IV-infused psilocin) had completed a 4-week follow-up assessment. The company said top-line results showed clinically meaningful improvements across multiple symptom areas, following 2 TRP-8803 infusions over 3 weeks alongside supportive psychotherapy (per its 16 December 2025 ASX announcement).

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK